Together with established infant nutrition authorities in Europe, we have committed to a major long-term research program to identify and substantiate new Betapol® benefits. These studies have already indicated that Betapol® has a positive impact on brain function and physical development. These Sn-2 fat innovations will enable us to extend the Betapol® portfolio and further develop new OPO products and product combinations adding value to your brand.
“It has been proven that infant formulas containing Betapol® are much more easily absorbed by infants. Research also shows that Betapol® protects infants from the pain and discomfort of constipation, while improving calcium intestinal absorption.”
Virgilio P. Carnielli, MD, PhD, Professor of Neonatal Pediatrics, Polytechnical University of Marche.
Director of Neonatal Medicine, G. Salesi Hospital, Ancona, Italy.